1. Carretero A, León Z, García-Cañaveras JC, Zaragoza Á, Gómez-Lechón MJ, Donato MT, et al. In vitro/in vivo screening of oxidative homeostasis and damage to DNA, protein, and lipids using UPLC/MS-MS. Anal Bioanal Chem 2014;406(22):5465-76. PMID: 24969468 [
DOI:10.1007/s00216-014-7983-5]
2. Celardo I, Pedersen JZ, Traversa E, Ghibelli L. Pharmacological potential of cerium oxide nanoparticles. Nanoscale 2011;3(4):1411-20. PMID: 21369578 [
DOI:10.1039/c0nr00875c]
3. Liying HE, Yumin SU, Lanhong J, Shikao SH. Recent advances of cerium oxide nanoparticles in synthesis, luminescence and biomedical studies: a review. J Rare Earths 2015;33(8):791-9. Link [
DOI:10.1016/S1002-0721(14)60486-5]
4. Tonini T, Rossi F, Claudio PP. Molecular basis of angiogenesis and cancer. Oncogene 2003;22(42):6549-56. PMID: 14528279 [
DOI:10.1038/sj.onc.1206816]
5. Fam PN, Verma S, Kutryk M, Stewart JD. Clinician guide to angiogenesis. Circulation 2003;108(21):2613-8. PMID: 14638526 [
DOI:10.1161/01.CIR.0000102939.04279.75]
6. Folkman J. Proceedings: tumor angiogenesis factor. Cancer Res 1974;34(8):2109-13. PMID: 4842257
7. Conway EM, Collen D, Carmeliet P. Molecular mechanisms of blood vessel growth. Cardiovasc Res 2001;49(3):507-21. PMID: 11166264 [
DOI:10.1016/S0008-6363(00)00281-9]
8. Karamysheva AF. Mechanisms of angiogenesis. Biochemistry (Mosc) 2008;73(7):751-62. PMID: 18707583 [
DOI:10.1134/S0006297908070031]
9. Ucuzian AA, Gassman AA, East AT, Greisler HP. Molecular mediators of angiogenesis. J Burn Care Res 2010;31(1):158-75. PMID: 20061852 [
DOI:10.1097/BCR.0b013e3181c7ed82]
10. Ruhrberg C. Endogenous inhibitors of angiogenesis. J Cell Sci 2001;14(Pt 18):3215-6. PMID: 11591810
11. Martinez A. A new family of angiogenic factors. Cancer Lett 2006;236(2):157-63. PMID: 15927357 [
DOI:10.1016/j.canlet.2005.04.008]
12. Welti J, Loges S, Dimmeler S, Carmeliet P. Recent molecular discoveries in angiogenesis and antiangiogenic therapies in cancer. J Clin Invest 2013;123(8):3190-200. PMID: 23908119 [
DOI:10.1172/JCI70212]
13. Egginton S. Invited review: activity-induced angiogenesis. Pflugers Arch 2009;457(5):963-77. PMID: 18704490 [
DOI:10.1007/s00424-008-0563-9]
14. Shibuya M. VEGF-VEGFR signals in health and disease. Biomol Ther (Seoul) 2014;22(1):1-9. PMID: 24596615 [
DOI:10.4062/biomolther.2013.113]
15. Friesel RE, Maciag T. Molecular mechanisms of angiogenesis: fibroblast growth factor signal transduction. FASEB J 1995;9(10):919-25. PMID: 7542215 [
DOI:10.1096/fasebj.9.10.7542215]
16. Pasquet M, Golzio M, Mery E, Rafii A, Benabbou N, Mirshahi P, et al. Hospicells (ascites-derived stromal cells) promote tumorigenicity and angiogenesis. Int J Cancer 2010;126(9):2090-101. PMID: 19739074 [
DOI:10.1002/ijc.24886]
17. Semenza LG. Vasculogenesis, angiogenesis, and arteriogenesis: mechanisms of blood vessel formation and remodeling. J Cell Biochem 2007;102(4):840-7. PMID: 17891779 [
DOI:10.1002/jcb.21523]
18. Heyadri M, Hashempur MH, Ayati MH, Quintern D, Nimrouzi M, Mosavat SH. The use of Chinese herbal drugs in Islamic medicine. J Integr Med 2015;13(6):363-7. PMID: 26559361 [
DOI:10.1016/S2095-4964(15)60205-9]
19. Lokman NA, Elder AS, Ricciardelli C, Oehler MK. Chick chorioallantoic membrane (CAM) assay as an in vivo model to study the effect of newly identified molecules on ovarian cancer invasion and metastasis. Int J Mol Sci 2012;13(8):9959-70. PMID: 22949841 [
DOI:10.3390/ijms13089959]
20. Ramezani T, Baharara J. A review on angiogenesis in tumor. J Cell Tissue 2014;5(1):89-100. Link [
DOI:10.5899/2014/ijcmb-00015]
21. Huang D, Lan H, Liu F, Wang S, Chen X, Jin K, et al. Anti-angiogenesis or pro-angiogenesis for cancer treatment: focus on drug distribution. Int J Clin Exp Med 2015;8(6):8369-76. PMID: 26309490
22. Mawalla B, Yuan X, Luo X, Chalya PL. Treatment outcome of anti-angiogenesis through VEGF-pathway in the management of gastric cancer: a systematic review of phase II and III clinical trials. BMC Res Notes 2018;11(1):21. PMID: 29329598 [
DOI:10.1186/s13104-018-3137-8]
23. Kong DH, Kim MR, Jang JH, Na HJ, Lee S. A review of anti-angiogenic targets for monoclonal antibody cancer therapy. Int J Mol Sci 2017;18(8):E1786. PMID: 28817103 [
DOI:10.3390/ijms18081786]
24. Das S, Singh S, Dowding JM, Oommen S, Kumar A, Sayle TX, et al. The induction of angiogenesis by cerium oxide nanoparticles through the modulation of oxygen in intracellular environments. Biomaterials 2012;33(31):7746-55. PMID: 22858004 [
DOI:10.1016/j.biomaterials.2012.07.019]
25. Giri S, Karakoti A, Graham RP, Maguire JL, Reilly CM, Seal S, et al. Nanoceria: a rare-earth nanoparticle as a novel anti-angiogenic therapeutic agent in ovarian cancer. PloS One 2013;8(1):e54578. PMID: 23382918 [
DOI:10.1371/journal.pone.0054578]
26. Safavi E, Homayouni TM, Karimi E. Investigation of antiangiogenic properties of green ZnO nanoparticles synthesized by root extract of persicaria bistorta. J Ilam Univ Med Sci 2018;26(2):45-56. Link [
DOI:10.29252/sjimu.26.2.45]